Lowering cholesterol after carotid surgery for better outcomes
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests if providing improved medication and follow-up care after carotid artery surgery can help patients reach healthy cholesterol levels. The goal is to see if these efforts lead to better long-term heart and brain health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with a narrowing of the carotid artery.
- You are scheduled to have surgery to open that artery (carotid endarterectomy).
- Your LDL ('bad') cholesterol is above 55 mg/dL before the surgery.
- You are willing to take part and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients who have had carotid artery surgery to see if the artery narrows again. It helps doctors understand how well the surgery works over time.
This study looks at strategies to improve cholesterol treatment in adults whose brain arteries are narrowed and who have had symptoms. Better cholesterol management may help reduce future problems related to this condition.
This trial tests whether adding a PCSK9 inhibitor to a statin is better than a statin alone for people with mild-to-moderate narrowing of the carotid artery (the main artery in the neck). It looks at how well these treatments slow plaque buildup and prevent strokes.
This trial tests whether a single injection of a PCSK9 inhibitor (a cholesterol-lowering medicine) can improve heart health after a stent procedure. It is for people who have a certain amount of fat buildup in their treated artery.
This study tests whether an educational program can help people with high cholesterol and heart disease get their LDL cholesterol levels lower. It involves watching online videos and working with your doctor to adjust treatments.
This trial tests if adding a PCSK9 inhibitor (a newer cholesterol-lowering medicine) to standard care helps people who had a stroke from a large artery blockage and had a clot-removal procedure. It may lower bad cholesterol further and reduce the risk of another stroke.
Hear when a new Dyslipidaemias trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.